BAP1 loss augments sensitivity to BET inhibitors in cancer cellsYuyan Xu(Southern Medical University), Le Yu(Southern Medical University)Acta Pharmacologica SinicaNovember 4, 202110.1038/s41401-021-00783-5Cited by 13SaveCiteExport RISWatch citationsRelated PapersObatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells|Oncotarget|2016|36[RITA selectively inhibits proliferation of <i>BAP1</i>-deficient cutaneous melanoma cells <i>in vitro</i>].|PubMed|2023|0